# Refractive Error and Biometry in Retinopathy of Prematurity

> **NCT03334513** · — · COMPLETED · sponsor: **San Ni Chen** · enrollment: 35 (actual)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT03334513
- **Lead sponsor:** San Ni Chen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-01
- **Primary completion:** 2014-04-01
- **Final completion:** 2014-04-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2017-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03334513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03334513, "Refractive Error and Biometry in Retinopathy of Prematurity". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT03334513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*